virus_spore_10023-3_edited_edited.png

VMS+ IS A LIFELINE

 

Blue Online Doctor Consulation Instagram
IN THE FIGHT AGAINST COVID-19

 

SUPERIOR QUANTIFICATION

KBR IS POWER

The VMS's KBR  technology produces accurate and reproducible ejection fractions  and volume measurements for all four chambers by simply  using data obtained from an echo scan.  Results are comparable to MRI. In addition, results for right ventricle possible with only sparse data. 

Journal of Invasive Cardiology

A  recent study from the Icahn school of medicine at Mount Sinai in New York city concludes that a dilated RV is known to predict mortality in patients that contracted Covid-19 and reported to emergency. In interest of infection control and the need for bedside tools, the study authors recommend using echocardiography as a means of assessing those at risk.

Right Ventricular Dilation in Hospitalized Patients With COVIDClerkin K.J., Fried J.A., Raikhelkar J., et al."Coronavirus disease 2019 (COVID-19 ) and cardiovascular disease". Circulation 2020;141:1648-1655.

virus_spore_10023-3_edited_edited.png

 

 

MANAGE THE EXPECTED 

the virus is affecting the heart.

virus_spore_10023-3_edited_edited.png

We still do not know if the virus could give rise to new cardiac conditions.  this  and now we  thus, leading to the entry of new technologies that can be effectively use to monitor the heart during a time to which strict infection control is being enforced.

The VMS has many features that makes the system ideal for monitoring a Covid -19 patients' heart during a pandemic

Blue Online Doctor Consulation Instagram

Point of care technology

with limited contact

VMS is a point of care technology that  follows the typical workflow of a sonographer or cardiologist during his or her initial examination of a patient. Thus, limited contact with patient.

Integration  in hospital and clinic settings 

The VMS was designed to be part of the standard echo exam which required us to only use standard images that conform to DICOM standards and all images can be stored on PACS.

Infection control

The VMS can be easily cleaned with hospital cleaning agents. The system can be easily installed in the hospital infrastructure.  remotely.

Remote installation

We have remotely installed the system in North America and European countries to accommodate any hospitals' pandemic safety measures. 

Scientific Reports

 

A 12 year follow up study showed that of 25 patients, 11 patients (44%) were reporting cardiovascular abnormalities.   

 

Wu Q, Zhou L, Sun X, et al. Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection. Sci Rep. 2017;7(1):9110. Published 2017 Aug 22. doi:10.1038/s41598-017-09536-z 

 

 San Francisco-based Gladstone Institutes,

 

Scientists made a number of observations when SARS-CoV-2 virus was added to human heart cells grown in lab dishes, the long muscle fibers that keep hearts beating were diced into short bits.  The fiber fragments  bore no resemblance to the disintegration seen in other acquired or hereditary diseases of the heart muscle. Further to this, there were black holes where DNA should have been in the nucleus of these cells.   While this was a petri dish experiment, the scientists saw a similar phenomenon in heart tissue from Covid-19 patients’ autopsies. 

Want to talk to us about VMS +?

Talk to a representative to learn how VMS+ can be used to aid in more accurate volumes and ejection fractions so you can follow patients with confidence.

CONTACT US

 

 Jama cardiology 

 

A German study reviewed the MRI scans of 100 recovering patients, who  contracted Covid but did not have any known cardiac condition,  after two months of recovery time.  The researchers found that:

                           78% had cardiac involvement, 

                            60% had myocardial inflammation   

 

Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265–1273. doi:10.1001/jamacardio.2020.3557